Increasing Adherence And Access Through Innovation for Global Health
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: HERSHENSON, Susan (Bill & Melinda Gates Foundation, Integrated Development, Seattle, United States)
- Co-author(s): Susan Hershenson: Integrated Development, Bill & Melinda Gates Foundation, Seattle, United States
Drug development for Global Health applications faces additional hurdles beyond the already substantial challenges inherent in drug development for the developed world. The drug product must be stable for long periods under extreme climate conditions with limited cold chain; sufficiently rugged to reach patients and providers in remote areas;.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.